Literature DB >> 22869351

Does stress-induced release of interleukin-1 cause liver injury?

Vadim Tseilikman1, Denis Kozochkin, Anton Synitsky, Sergey Sibiriak, Olga Tseilikman, Eugene Katashinsky, Anna Nikitina, Dmitry Vinogradov, Andrey Simbirtsev.   

Abstract

It is well established that repeated immobilization stress (RIS) is induced by increased levels of cytokines and the emergence of lesions in the liver. Our data prove that interleukin-1 (IL-1) causes liver lesions in stressed Wistar rats. In essence, the relationship between IL-1 and stress-induced liver injury is based on three findings: (1) IL-1β treatment causes liver inflammation, consisting of infiltrating monocytes and the appearance of necrosis by increasing lipid peroxidation and protein carbonylation. Positive correlations between the content of heptane-soluble diene conjugates and an area of necrosis, as well as between content carbonylated proteins and an area of necrosis, were found after injection of IL-1β to unstressed rats. (2) RIS is accompanied by increased levels of circulating IL-1β and corticosterone. In the liver, stress causes the emergence of foci of necrosis with perivascular and lobular infiltration of mononuclear cells as well as increased free radical oxidation. Moreover, there were observed down-regulations of cytochrome P450 (CYP)-dependent enzymes, CYP1A1 activities, and decreased CYP1A1 mRNA content. Positive correlations between the level of circulating IL-1β and necrosis areas, as well as between circulating IL-1β and the content of heptane-soluble diene conjugates, were observed in stressed rats. In addition, the positive correlation between necrosis foci and heptane-soluble diene conjugates was revealed after stress cessation. (3) Use of the IL-1 receptor antagonist Anakinra at a dose of 2 μg/kg to treat the effects of stress prevents infiltration of mononuclear cells and reduces the level of free radical oxidation as well as necrosis of lesions. As a result, blocking IL-1 receptors with an antagonist significantly rescues stress-induced liver injury, suggesting that IL-1 might be involve in the cascade of liver injury that initiated by sustained stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22869351     DOI: 10.1007/s10571-012-9866-7

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  38 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Effects of stressors and immune activating agents on peripheral and central cytokines in mouse strains that differ in stressor responsivity.

Authors:  Julie Gibb; Shawn Hayley; Michael O Poulter; Hymie Anisman
Journal:  Brain Behav Immun       Date:  2010-11-18       Impact factor: 7.217

3.  Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.

Authors:  A Gadek-Michalska; J Bugajski
Journal:  J Physiol Pharmacol       Date:  2005-09       Impact factor: 3.011

Review 4.  Regulation of cytochrome p450 by inflammatory mediators: why and how?

Authors:  E T Morgan
Journal:  Drug Metab Dispos       Date:  2001-03       Impact factor: 3.922

5.  Chronic stress differentially affects antioxidant enzymes and modifies the acute stress response in liver of Wistar rats.

Authors:  J Djordjevic; A Djordjevic; M Adzic; A Niciforovic; M B Radojcic
Journal:  Physiol Res       Date:  2010-04-20       Impact factor: 1.881

6.  Thiol oxidative stress induced by metabolic disorders amplifies macrophage chemotactic responses and accelerates atherogenesis and kidney injury in LDL receptor-deficient mice.

Authors:  Mu Qiao; Qingwei Zhao; Chi Fung Lee; Lisa R Tannock; Eric J Smart; Richard G LeBaron; Clyde F Phelix; Yolanda Rangel; Reto Asmis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-10       Impact factor: 8.311

7.  Interleukin-1 participates in the progression from liver injury to fibrosis.

Authors:  Roben G Gieling; Karen Wallace; Yuan-Ping Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-02       Impact factor: 4.052

8.  Rapid inibition of basal and glucose-stimulated insulin release by xylazine.

Authors:  I D Goldfine; A I Arieff
Journal:  Endocrinology       Date:  1979-10       Impact factor: 4.736

9.  Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver.

Authors:  Vladimir Savransky; Shannon Bevans; Ashika Nanayakkara; Jianguo Li; Philip L Smith; Michael S Torbenson; Vsevolod Y Polotsky
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-08-09       Impact factor: 4.052

10.  Chemotactic activity of the lipid peroxidation product 4-hydroxynonenal and homologous hydroxyalkenals.

Authors:  M Curzio; H Esterbauer; C Di Mauro; G Cecchini; M U Dianzani
Journal:  Biol Chem Hoppe Seyler       Date:  1986-04
View more
  4 in total

Review 1.  A literature review for the mechanisms of stress-induced liver injury.

Authors:  Jin-Yong Joung; Jung-Hyo Cho; Yun-Hee Kim; Seung-Hoon Choi; Chang-Gue Son
Journal:  Brain Behav       Date:  2019-02-13       Impact factor: 2.708

2.  An Herbal Formula CGplus Ameliorates Stress-Induced Hepatic Injury in a BALB/c Mouse Model.

Authors:  Hyeong-Geug Kim; Yun-Hee Kim; Sung-Bae Lee; Jin-Seok Lee; Sung-Wook Chae; Dong-Gu Kim; Chang-Gue Son
Journal:  Front Pharmacol       Date:  2020-04-14       Impact factor: 5.810

3.  Acceleration of TAA-Induced Liver Fibrosis by Stress Exposure Is Associated with Upregulation of Nerve Growth Factor and Glycopattern Deviations.

Authors:  Catalina Atorrasagasti; Flavia Piccioni; Sophia Borowski; Irene Tirado-González; Nancy Freitag; María José Cantero; Juan Bayo; Guillermo Mazzolini; Laura D Alaniz; Sandra M Blois; Mariana G Garcia
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

4.  IL-1α correlates with severity of hepatitis C virus-related liver diseases.

Authors:  Ahmed Khaled Tawfik; Ahmed Mustafa Amin; Mohamed Yousef; Noha Mohamed El-Sayd; Heba Elashry; Mahmoud Elkadeem; Sherief Abd-Elsalam
Journal:  J Inflamm Res       Date:  2018-07-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.